Completed Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342 Conditions Acoustic Neuroma, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +61 more Locations Yale New Haven Hospital — New Haven, Connecticut, United States Massachusetts General Hospital — Boston, Massachusetts, United States Brigham & Women's Hospital — Boston, Massachusetts, United States University of Missouri — Columbia, Missouri, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors NCT01151670 Conditions Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +31 more Locations Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States View Trial Details
